Prospects of Benefits for Applied DNA Science


Applied DNA Sciences APDN is expected to release its latest quarterly earnings report on Thursday 05/12/2022. Here’s what investors need to know ahead of the announcement.

Analysts estimate that Applied DNA Sciences will report a earnings per share (EPS) of -$0.33.

The Applied DNA Sciences bulls are hoping to hear the company announce that it has not only beaten that estimate, but also provided positive guidance, or expected growth, for the next quarter.

New investors should note that sometimes it’s not an earnings beat or miss that most affects a stock’s price, but direction (or forecast).

Historical Earnings Performance

Last quarter, the company missed EPS by $0.36, followed by a 15.11% decline in share price the next day.

Here is an overview of Applied DNA Sciences past performance and the resulting price movement:

Trimester Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS estimate -0.27 -0.37 -0.22 -0.21
Actual EPS -0.63 -0.60 -0.46 -0.33
Price change % -15.11% -3.54% -3.06% 4.22%

Stock performance

Applied DNA Sciences shares were trading at $1.29 as of May 10. Over the past 52-week period, shares are down 79.05%. Since these yields are typically negative, long-term shareholders are likely bearish ahead of this earnings release.

To keep track of all earnings releases for Applied DNA Sciences, visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.


About Author

Comments are closed.